FDA Concludes Invokana, SGLT2 Inhibitors, Pose Serious Risks

By |2020-11-25T14:44:41+00:00December 12th, 2015|

Friday, December 4, the FDA announced that its concerns about SGLT2 inhibitors were confirmed. FDA Concludes Invokana, SGLT2 Inhibitors, Pose Serious Risks. In May 2015, the FDA announced it was investigating [...]